Hydroxychloroquine as Prophylaxis for COVID-19: A Review

Hydroxychloroquine as Prophylaxis for COVID-19: A Review

The impact of the COVID-19 pandemic worldwide has led to a desperate search for effective drugs and vaccines. There are still no approved agents for disease prophylaxis. We thus decided to use a drug repositioning strategy to perform a state-of-the-art review of a promising but controversial drug, h...

Full description

Bibliographic Details
Main Authors:	Manuela Monti, Bernadette Vertogen, Carla Masini, Caterina Donati, Claudia Lilli, Chiara Zingaretti, Gerardo Musuraca, Ugo De Giorgi, Claudio Cerchione, Alberto Farolfi, Pietro Cortesi, Pierluigi Viale, Giovanni Martinelli, Oriana Nanni
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Pharmacology
Subjects:	hydroxychloroquine prophylaxis COVID-19 review clinical trials
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.605185/full

Similar Items

PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial
by: Oriana Nanni, et al.
Published: (2020-07-01)

The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article
by: Shagun B Shah, et al.
Published: (2020-01-01)

Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
by: Praveen Balabaskaran Nina, et al.
Published: (2020-01-01)

Hydroxychloroquine/chloroquine prophylaxis among health-care workers: Was it really preventive? – Evidence from a multicentric cross-sectional study
by: Arun Kumar Yadav, et al.
Published: (2022-01-01)

Efficacy of hydroxychloroquine in pre-exposure severe acute respiratory syndrome coronavirus 2 prophylaxis among high-risk healthcare workers: A multicenter study
by: Elahe Nasri, et al.
Published: (2023-01-01)

Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
by: Berta Grau-Pujol, et al.
Published: (2021-11-01)

Impact of Prophylactic Hydroxychloroquine on People at High Risk of COVID-19: A Systematic Review and Meta-Analysis
by: Adrian V. Hernandez, et al.
Published: (2021-06-01)

Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 health-care workers at the first third of 2020
by: Anne-Lise Bienvenu, et al.
Published: (2020-12-01)

The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials
by: Amit Malviya
Published: (2020-10-01)

Hydroxychloroquine pre-exposure prophylaxis for COVID-19 among healthcare workers: Initial experience from India
by: Harshith B Kadnur, et al.
Published: (2022-01-01)

Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis
by: Raphael B. Stricker, et al.
Published: (2021-09-01)

Serosurvey for Health-Care Workers Provides Supportive Evidence for the Effectiveness of Hydroxychloroquine Prophylaxis against SARS-CoV-2 Infection
by: Reetika Malik Yadav, et al.
Published: (2021-05-01)

Hospital-Based Quasi-Experimental Study on Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Providers with Its Potential Side-Effects
by: Lubaba Shahrin, et al.
Published: (2022-12-01)

Clinical spectrum, transmission dynamics, outcome and hydroxychloroquine prophylaxis in COVID-19 positive health care workers at a tertiary care hospital
by: Shiwangi Sharma, et al.
Published: (2021-01-01)

Knowledge and compliance of hydroxychloroquine prophylaxis for severe acute respiratory syndrome coronavirus 2 infection among Indian health-care workers
by: Rudrashish Haldar, et al.
Published: (2022-01-01)

Hydroxychloroquine as pre-exposure prophylaxis against COVID-19 in health-care workers: A single-center experience
by: Sheila Samanta Mathai, et al.
Published: (2020-01-01)

Cutaneous side effects of hydroxychloroquine in health care workers in a COVID referral hospital – implications for clinical practice
by: Kabir Sardana, et al.
Published: (2022-02-01)

Hydroxychloroquine for post-exposure prophylaxis of COVID-19 among naval personnel in Sri Lanka: study protocol for a randomized, controlled trial
by: Madunil A. Niriella, et al.
Published: (2020-08-01)

Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro
by: Nicola Clementi, et al.
Published: (2020-07-01)

Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea
by: Seongman Bae, et al.
Published: (2021-02-01)

Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study
by: Peter Kamstrup, et al.
Published: (2021-07-01)

Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?
by: Pathiyil Ravi Shankar, et al.
Published: (2021-01-01)

Extreme Interocular Asymmetry in an Atypical Case of a Hydroxychloroquine-Related Retinopathy
by: Gabriel Hallali, et al.
Published: (2022-07-01)

Pre-Exposure Prophylaxis with Hydroxychloroquine Does Not Prevent COVID-19 nor Virus Related Venous Thromboembolism
by: Alessandro Perrella, et al.
Published: (2021-10-01)

The use of Hydroxychloroquine in the Treatment of COVID-19
by: Kamer TECEN-YÜCEL, et al.
Published: (2020-09-01)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2020-12-01)

Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women
by: Fesler MC, et al.
Published: (2021-01-01)

Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial
by: Ruanne V. Barnabas, et al.
Published: (2020-06-01)

SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis
by: Khalid M. Dousa, et al.
Published: (2020-01-01)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

Hydroxychloroquine for the treatment of COVID-19: an approach based on the philosophy of science and heuristics
by: Davi Jorge Fontoura Solla
Published: (2020-05-01)

Unusual Fundus Autofluorescence Appearance in a Patient with Hydroxychloroquine Retinal Toxicity
by: Sleiman Abou-Ltaif
Published: (2015-06-01)

The prophylactic effect of hydroxychloroquine on the severity of COVID-19 infection in an asymptomatic population: A randomized clinical trial
by: Arezoo Chouhdari
Published: (2024-01-01)

Effect the pre-exposure prophylactic of hydroxychloroquine on severe COVID-19 disease: a randomized controlled trial
by: Mahnaz Valizadeh, et al.
Published: (2023-12-01)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
by: Filippo Albani, et al.
Published: (2020-08-01)

Cutaneous purpura of Sjögren syndrome successfully treated with hydroxychloroquine
by: Grace A. Hile, BS, et al.
Published: (2017-07-01)

Macular toxicity after short-term hydroxychloroquine therapy
by: Isil Pasaoglu, et al.
Published: (2019-01-01)

Therapeutic status of hydroxychloroquine in COVID-19: A review
by: Kirandeep Kaur, et al.
Published: (2020-01-01)

Hydroxychloroquine retinopathy: A review of imaging
by: Hemang K Pandya, et al.
Published: (2015-01-01)

Implications of the use of hydroxychloroquine on cardioactive drugs
by: Soumitra Ghosh, et al.
Published: (2021-01-01)